Scientific literature review of lung transplantation

Australian Health Technology Advisory Committee
Record ID 31999009312
English
Authors' objectives:

This document was produced for AHTAC as a supporting document to the 'Superspecialty service guidelines for lung transplantation services'. It assesses the effectiveness and cost-effectiveness of lung transplantation and alternative treatment.

Authors' recommendations: The overall 5-year survival rate for LT is 42% according to the ISHLT Registry. Current long-term survival figures are probably better, with some reviewers suggesting that at least a 50% 5-year survival rate can now be expected. The main causes of early death after LT are infection and graft failure; while infection and rejection/obliterative bronchiolitis (OB) are the major causes for late death. Compared with other solid-organ transplantation, LT recipients tend to have more frequent and more life-threatening infections. Overall, prolongation of average survival by LT has not been unequivocally substantiated. Medical treatment can be an effective long-term palliation to successful LT as well as a possible alternative treatment in selected children and adults. Lung reduction in selected LT candidates with end-stage emphysema has the potential to provide an alternative to LT.
Authors' methods: Overview
Details
Project Status: Completed
URL for project: http://www.msac.gov.au/
Year Published: 1998
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Costs and Cost Analysis
  • Lung Diseases
  • Lung Transplantation
  • Quality of Life
Contact
Organisation Name: Australian Health Technology Advisory Committee
Contact Address: Naarilla Hirsch, Australian Institute of Health and Welfare Health Technology Unit, GPO Box 570, Canberra, ACT, 2601, Australia
Copyright: Australian Health Technology Advisory Committee
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.